MCL1 and cholangiocarcinoma: In contrast to the myofibroblast cells, human CCA cells did not exhibit apoptotic sensitization to navitoclax after PDGF treatment (Fig. 2C), likely due to their known overexpression of Mcl-1, which does not bind navitoclax (3).